Skip to main content

DEA: Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

The DEA passed a temporary rule, Temporary Extension of COVID19 Telemedicine Flexibilities for Prescription of Controlled Medications, in response comments received from previously proposed rules. The temporary rule goes into effect on May 12, 2023 (the first day after the PHE expires) and will expire at the end of the day on November 11, 2024.  (However, there are nuances so please read the full rule linked here.)

File Type: pdf
Categories: Patients, Providers, Researchers
Tags: DEA, temporary ruling